AIM ImmunoTech, Inc. (AIM)
1.34
+0.03
(+2.29%)
USD |
NYAM |
Jan 15, 16:00
1.38
+0.04
(+2.99%)
After-Hours: 20:00
AIM ImmunoTech SG&A Expense (TTM): 10.06M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Halozyme Therapeutics, Inc. | 172.31M |
| Agenus, Inc. | 63.03M |
| Curis, Inc. | 14.52M |
| Protalix Biotherapeutics, Inc. | 11.16M |
| Armata Pharmaceuticals, Inc. | 12.31M |